The American College of Rheumatology (ACR) 2024 Convergence has just concluded, showcasing significant advancements and ...

Lupus nephritis (LN) diagnosis could improve greatly if early results with a multimarker urine test are confirmed in larger ...

1 The purpose of ALMS was to demonstrate the superiority of mycophenolate mofetil (MMF) over intravenous cyclophosphamide for the induction of remission in patients with lupus nephritis.

Lupus nephritis is an inflammatory kidney disease (glomerulonephritis) that develops in patients with systemic lupus erythematosus (SLE). In patients with SLE, the immune system is not properly ...

Experts have called for greater awareness of lupus to promote better access to healthcare for those living with the condition ...

Aurinia Pharmaceuticals (AUPH) has released an update. Aurinia Pharmaceuticals has unveiled new data underscoring the importance of early ...

Regular assessment of renal function, proteinuria, and serological markers is crucial for monitoring lupus nephritis progression and treatment response. Long-term follow-up data offer valuable ...

Individual patient characteristics, such as disease severity and comorbidities, significantly influence lupus nephritis treatment decisions. Steroid use requires careful balancing to maximize ...

Attendees can also look forward to the unveiling of new lupus nephritis guidelines, reflecting over a year of effort by experts. Additionally, there will be sessions on the potential of cell ...